AIM ImmunoTech Correlations
| AIM Stock | USD 9.36 0.09 0.97% |
The current 90-days correlation between AIM ImmunoTech and Quoin Pharmaceuticals Ltd is 0.07 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AIM ImmunoTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AIM ImmunoTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
AIM ImmunoTech Correlation With Market
Average diversification
The correlation between AIM ImmunoTech and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AIM ImmunoTech and DJI in the same portfolio, assuming nothing else is changed.
Moving against AIM Stock
| 0.58 | ICUCW | LMF Acquisition Oppo | PairCorr |
| 0.46 | KRYS | Krystal Biotech | PairCorr |
| 0.35 | ANIK | Anika Therapeutics | PairCorr |
| 0.61 | PG | Procter Gamble | PairCorr |
Related Correlations Analysis
| 0.21 | -0.47 | 0.0 | 0.67 | -0.74 | 0.57 | QNRX | ||
| 0.21 | 0.27 | 0.0 | 0.18 | -0.25 | 0.21 | COCP | ||
| -0.47 | 0.27 | 0.0 | -0.07 | 0.13 | -0.04 | IBIO | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | BPTH | ||
| 0.67 | 0.18 | -0.07 | 0.0 | -0.81 | 0.4 | AYTU | ||
| -0.74 | -0.25 | 0.13 | 0.0 | -0.81 | -0.51 | CODX | ||
| 0.57 | 0.21 | -0.04 | 0.0 | 0.4 | -0.51 | NNVC | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between AIM Stock performing well and AIM ImmunoTech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AIM ImmunoTech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| QNRX | 3.58 | 0.40 | 0.05 | 1.30 | 4.54 | 9.33 | 26.24 | |||
| COCP | 3.20 | 0.47 | 0.10 | 1.28 | 2.94 | 9.09 | 23.33 | |||
| IBIO | 5.36 | (1.01) | 0.00 | (0.50) | 0.00 | 11.11 | 32.30 | |||
| BPTH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AYTU | 5.63 | 1.91 | 0.35 | 5.53 | 3.74 | 5.71 | 109.61 | |||
| CODX | 3.98 | (0.42) | 0.00 | 2.05 | 0.00 | 7.69 | 26.71 | |||
| NNVC | 3.78 | 0.40 | 0.04 | 7.12 | 3.90 | 11.76 | 33.09 |
AIM ImmunoTech Corporate Management
| Wayne Springate | Senior Vice President - Operations | Profile | |
| III Esq | Exec COO | Profile | |
| Ann Coverly | Director Coordinator | Profile | |
| MBA IV | Chief Officer | Profile | |
| Stewart Appelrouth | Director | Profile |